AGC Biologics
  • About Us
    • History
    • Executive Leadership
  • Capabilities
    • Overview
    • Process Development
      • Cell Line Development
      • Upstream Process Development
      • Downstream Process Development
      • Formulation Development
      • Analytical Development
    • cGMP Manufacturing
    • Plasmid DNA
    • Viral Vector
    • Cell Therapy
    • Quality and Regulatory
    • Process Validation
  • Resources
    • Videos
    • Case Studies
      • Robust, Scalable Manufacturing
      • Process Validation
      • Accelerated Antibody Production
      • Perfusion Production
    • Fact Sheets
    • Industry Links
    • Environmental Policy
  • Facilities
    • Seattle
    • Boulder
    • Copenhagen
    • Heidelberg
    • Milan & Bresso
    • Chiba
  • News & Events
    • News
    • Events
  • Join Our Team
    • Amplify Your Career
    • Employee Testimonials
    • Seattle Careers
    • Boulder Careers
    • Copenhagen Careers
    • Heidelberg Careers
    • Milan & Bresso Careers
  • Contact Us

Group Business Ethics

  • Code of Conduct for North America (English)
  • Code of Conduct for Europe (English)
  • Code of Conduct for Europe (German)
  • Code of Conduct for Europe (Italian)
  • Code of Conduct for Japan (English)
  • Code of Conduct for Japan (Japanese)
  • Organizational Model of AGC Biologics S.p.A. (English)
  • Organizational Model of AGC Biologics S.p.A. (Italian)

Please take the time to read these Policies carefully. AGC Biologics may update these policies from time to time in response to changing legal, technical or business developments. When we update our Policies, we will take appropriate measures to inform you, consistent with the significance of the changes we make, if required by applicable law.

CODE OF CONDUCT FOR NORTH AMERICA (ENGLISH)

CODE OF CONDUCT FOR EUROPE (ENGLISH)

CODE OF CONDUCT FOR EUROPE (GERMAN)

CODE OF CONDUCT FOR EUROPE (ITALIAN)

CODE OF CONDUCT FOR JAPAN (ENGLISH)

CODE OF CONDUCT FOR JAPAN (JAPANESE)

ORGANIZATIONAL MODEL OF AGC BIOLOGICS S.p.A.(ENGLISH)

ORGANIZATIONAL MODEL OF AGC BIOLOGICS S.p.A.(ITALIAN)

  • About
  • Capabilities
  • Resources
  • Facilities
  • News & Events
  • Legal & Compliance
  • Contact Us
Follow us on LinkedIn Follow us on Twitter Follow us on Facebook

Events

BIO International Convention goes Virtual June 8 - 11, 2020
BioProcess International European Summit, July 13-16, 2020, Amsterdam
MIXiii BIOMED, September 7-9, 2020, Tel Aviv, Israel
Bio-Europe will be held October 26 - 28, 2020, Munich Germany
BIO Japan October 14 - 16, 2020 in Yokohama, Japan

News

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics’ Newly Approved Libmeldy™
Pierre Fabre Selects AGC Biologics as CDMO to Manufacture the Orphan Drug ER-004
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
AGC Biologics and Horizon Therapeutics plc Expand Partnership

LOCATIONS

SEATTLE, WASHINGTON (Headquarters)

BOULDER, COLORADO

COPENHAGEN, DENMARK

HEIDELBERG, GERMANY

MILAN, ITALY

BRESSO, ITALY

CHIBA, JAPAN

 ©2020 AGC Biologics. All Rights Reserved.   Website Privacy Policy